<div id="readability-page-1"><p>In a report released today, Luisa Hector from Berenberg Bank maintained a Buy rating on Sanofi, with a price target of <span id="expert-recommendation-target">€105.00</span>.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>Hector covers the Healthcare sector, focusing on stocks such as Sanofi, Roche Holding AG, and Merck &amp; Company. According to TipRanks, Hector has an average return of <span>6.3%</span> and a 62.50% success rate on recommended stocks. </p> <p>In addition to Berenberg Bank, Sanofi also received a Buy from Deutsche Bank ‘s Emmanuel Papadakis in a report issued on December 16. However, on December 17, Kepler Capital  maintained a Hold rating on Sanofi (Other OTC: SNYNF).</p></div>

SNYNF

<p>Berenberg Bank's Luisa Hector maintained a Buy rating for Sanofi with a price target of €105.00. Hector, who covers the Healthcare sector, has an average return of 6.3% and a 62.50% success rate. Deutsche Bank also rated Sanofi as Buy, while Kepler Capital maintained a Hold rating.</p>

Berenberg Bank Sticks to Their Buy Rating for Sanofi (SNYNF)